SCHEMBL239429

SCHEMBL239429

CC1(C)CC[N]CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7308851 0.87
SCHEMBL293108 0.79
SCHEMBL5432 0.73
SCHEMBL8397539 0.73
SCHEMBL7347322 0.72 NOS3 (0.31)
SCHEMBL739757 0.72
SCHEMBL1376128 0.72
Ammonia Solution, Strong SCHEMBL2985898 0.69
SCHEMBL2024892 0.69
Hydrochloric Acid SCHEMBL7031098 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 487 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024051766-A1 MOLECULAR GLUE COMPOUND BASED ON CEREBLON PROTEIN DESIGN AND USE THEREOF 标新生物医药科技(上海)有限公司 2024-03-14 WO claimed
WO-2024028169-A1 NOVEL SPECIFICALLY SUBSTITUTED THIOPHENOLIC COMPOUNDS NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2024-02-08 WO claimed
US-20220143002-A1 SULFUR-CONTAINING COMPOUND BASED ON GLUTARIMIDE SKELETON AND APPLICATION THEREOF SHANGHAITECH UNIVERSITY (CN) 2022-05-12 US claimed
US-20220002308-A1 AROMATIC RING-LINKED DIOXINO-QUINAZOLINE OR DIOXINO-QUINOLINE COMPOUNDS, COMPOSITIONS AND USE THEREOF BEIJING SCITECH-MQ PHARMACEUTICALS LIMITED (CN) 2022-01-06 US claimed
EP-3932922-A1 SULFUR-CONTAINING COMPOUND BASED ON GLUTARIMIDE SKELETON AND APPLICATION THEREOF ShanghaiTech University (CN) 2022-01-05 EP claimed
CN-109415387-B Arginase inhibitors and therapeutic uses thereof 昂科艾伦迪治疗法公司 2021-08-27 CN claimed
EP-3865487-A1 AROMATIC RING-LINKED DIOXANE-QUINAZOLINE OR -QUINOLINE COMPOUNDS, COMPOSITIONS AND USE THEREOF Beijing Scitech-MQ Pharmaceuticals Limited (CN) 2021-08-18 EP claimed
EP-3452485-B1 ARGINASE INHIBITORS AND THEIR THERAPEUTIC APPLICATIONS ONCOARENDI THERAPEUTICS SA (PL) 2020-09-09 EP claimed
US-10391077-B2 Arginase inhibitors and their therapeutic applications Oncoarendi Therapeutics S.A. (PL) 2019-08-27 US claimed
EP-3452485-A2 ARGINASE INHIBITORS AND THEIR THERAPEUTIC APPLICATIONS Oncoarendi Therapeutics SA (PL) 2019-03-13 EP claimed
WO-2003087064-A1 CHEMICAL COMPOUNDS WITH DUAL ACTIVITY, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS UCB, S.A. (BE) 2003-10-23 WO claimed
US-5716953-A MODIFIERS OF GASTRIN AND CHOLECYSTOKININS GLAXO WELLCOME S.P.A. (IT) 1998-02-10 US claimed
EP-0507672-B1 N-cyclohexyl benzamides derivatives, preparations and therapeutic applications thereof LOGEAIS LABOR JACQUES (FR) 1997-06-04 EP claimed
US-5585376-A 1,5-benzodiazepine derivatives having CCK and/or gastrin antagonistic activity GLAXO WELLCOME INC. (US) 1996-12-17 US claimed
EP-0694040-A1 1,5 BENZODIAZEPINE DERIVATIVES HAVING CCK AND/OR GASTRIN ANTAGONISTIC ACTIVITY GLAXO WELLCOME INC. (US) 1996-01-31 EP claimed
WO-1994024151-A1 1,5 BENZODIAZEPINE DERIVATIVES HAVING CCK AND/OR GASTRIN ANTAGONISTIC ACTIVITY GLAXO INC. (US) 1994-10-27 WO claimed
EP-0290145-B1 Aliphatic carboxamides ICI AMERICA INC (US) 1994-10-26 EP claimed
US-5273983-A 2-Piperidinylmethylcyclohexylaminocarbonyl-substituted benzene LABORATORIES JACQUES LOGEAIS (FR) 1993-12-28 US claimed
EP-0507672-A1 N-cyclohexyl benzamides derivatives, preparations and therapeutic applications thereof LABORATOIRES JACQUES LOGEAIS Société dite: (FR) 1992-10-07 EP claimed
EP-0290145-A1 Aliphatic carboxamides ZENECA INC. (US) 1988-11-09 EP claimed